Skip to content

Clinical trials

Completed Phase 1/2 Kidney Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Kidney Neoplasms Phase: Phase 1/2 Status: Completed Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20012
20021
20031
20042
20064
20072
20091
20102
20142
20151
20163
20201
20221
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Memorial Sloan Kettering Cancer Center3
Argos Therapeutics2
Fred Hutchinson Cancer Center2
Ludwig Institute for Cancer Research2
Amgen1
Beth Israel Deaconess Medical Center1
Duke University1
Fuda Cancer Hospital, Guangzhou1
Genzyme, a Sanofi Company1
Hoosier Cancer Research Network1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Kidney Neoplasms33
Carcinoma, Renal Cell17
Breast Neoplasms8
Melanoma7
Ovarian Neoplasms6
Prostatic Neoplasms5
Sarcoma5
Carcinoma, Non-Small-Cell Lung4
Colonic Neoplasms4
Head and Neck Neoplasms4

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.